1. Interplay of YEATS2 and GCDH regulates histone crotonylation and drives EMT in head and neck cancer

    This article has 7 authors:
    1. Deepak Pant
    2. Parik Kakani
    3. Rushikesh Joshi
    4. Abin Sabu
    5. Shruti Agrawal
    6. Atul Samaiya
    7. Sanjeev Shukla
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      These useful findings assigned a novel functional implication of histone acylation, crotonylation. Mechanistic insights have been provided in great detail regarding the role of the YEATS2-GCDH axis in modulating epithelial-to-mesenchymal transition (EMT) in head and neck cancer, and overall the strength of evidence is solid.

    Reviewed by eLife

    This article has 7 evaluationsAppears in 1 listLatest version Latest activity
  2. Deciphering the CD73⁺ Regulatory γδ T Cell ecosystem associated with poor survival in Ovarian cancer

    This article has 18 authors:
    1. Ghita Chabab
    2. Henri-Alexandre Michaud
    3. Cécile Dejou
    4. Laure-Agnès Chépeaux
    5. Yaël Glasson
    6. Florence Boissière
    7. Marion Lenain
    8. Anne-Sophie Dumé
    9. Pauline Sarrant
    10. Gabriel Chemin
    11. Pauline Wajda
    12. Bertrand Dubois
    13. Anna MacManus
    14. Pierre-Emmanuel Colombo
    15. Michel Fabbro
    16. Nathalie Bonnefoy
    17. Maeva Chauvin
    18. Virginie Lafont

    Reviewed by Review Commons

    This article has 4 evaluationsAppears in 1 listLatest version Latest activity
  3. Altered thymic niche synergistically drives the massive proliferation of malignant thymocytes

    This article has 3 authors:
    1. Erika Tsingos
    2. Advaita M Dick
    3. Baubak Bajoghli
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This important study combines agent-based modelling and in vivo experiments in medaka embryos to provide new insights into the role of the thymic niche in T cell development. The modelling yields some interesting and solid findings regarding the importance of thymic epithelial cells. This study would be of interest to oncologists, immunologists, and mathematical modelers.

    Reviewed by eLife

    This article has 10 evaluationsAppears in 1 listLatest version Latest activity
  4. Subtypes and proliferation patterns of small intestine neuroendocrine tumors revealed by single-cell RNA sequencing

    This article has 9 authors:
    1. Einav Somech
    2. Debdatta Halder
    3. Avishay Spitzer
    4. Chaya Barbolin
    5. Michael Tyler
    6. Reut Halperin
    7. Moshe Biton
    8. Amit Tirosh
    9. Itay Tirosh
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This is a valuable study that uses single-cell RNA sequencing to define tumor-intrinsic transcriptional programs that characterize distinct types of small intestine neuroendocrine tumors. The evidence supporting the claims of the authors is solid, but would benefit from a larger sample size. The work will be of interest to cancer biologists studying neuroendocrine tumors, as well as those studying tumor heterogeneity more broadly.

    Reviewed by eLife

    This article has 10 evaluationsAppears in 1 listLatest version Latest activity
  5. The long noncoding RNA lnc-FANCI-2 intrinsically restricts RAS signaling in human papillomavirus type 16-infected cervical cancer cells

    This article has 9 authors:
    1. Haibin Liu
    2. Lulu Yu
    3. Vladimir Majerciak
    4. Thomas J Meyer
    5. Ming Yi
    6. Peter F Johnson
    7. Maggie Cam
    8. Douglas R Lowy
    9. Zhi-Ming Zheng
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This study reports important new insights into the roles of a long noncoding RNA, lnc-FANCI-2, in the progression of cervical cancer induced by a type of human papillomavirus. Through a blend of cell biological, biochemical, and genetic analyses of RNA and protein expression, protein-protein interaction, cell signaling, and cell morphology, the authors provide convincing evidence that lnc-FANCI-2 affects cervical cancer outcome by regulating the RAS signaling pathway. These findings will be of interest to scientists in the fields of cervical cancer, long noncoding RNA, and cell signaling.

    Reviewed by eLife

    This article has 8 evaluationsAppears in 1 listLatest version Latest activity
  6. Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

    This article has 16 authors:
    1. Veera K. Ojala
    2. Sini Ahonen
    3. Sara Peltola
    4. Aura Tuohisto‐Kokko
    5. Olaya Esparta
    6. Peppi Suominen
    7. Anne Jokilammi
    8. Iman Farahani
    9. Deepankar Chakroborty
    10. Nikol Dibus
    11. Steffen Boettcher
    12. Tomi T. Airenne
    13. Mark S. Johnson
    14. Lisa D. Eli
    15. Klaus Elenius
    16. Kari J. Kurppa

    Reviewed by Review Commons

    This article has 4 evaluationsAppears in 1 listLatest version Latest activity
  7. Tumoral CD24 tunes platelets binding and pro-metastatic functions

    This article has 12 authors:
    1. Vincent Mittelheisser
    2. Cristina Liboni
    3. Clarisse Mouriaux
    4. Silvia Maria Grazia Trivigno
    5. Louis Bochler
    6. Maria Garcia-Leon
    7. Annabel Larnicol
    8. Laetitia Paulen
    9. Tristan Stemmelen
    10. Pierre Henri Mangin
    11. Olivier Lefebvre
    12. Jacky G. GOETZ

    Reviewed by preLights

    This article has 1 evaluationAppears in 1 listLatest version Latest activity
  8. PA28γ promotes the malignant progression of tumor by elevating mitochondrial function via C1QBP

    This article has 12 authors:
    1. Jiongke Wang
    2. Yujie Shi
    3. Ying Wang
    4. Yingqiang Shen
    5. Huan Liu
    6. Silu Sun
    7. Yimei Wang
    8. Xikun Zhou
    9. Yu Zhou
    10. Xin Zeng
    11. Jing Li
    12. Qianming Chen
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This manuscript determines how PA28g, a proteasome regulator that is overexpressed in tumors, and C1QBP, a mitochondrial protein for maintaining oxidative phosphorylation that plays a role in tumor progression, interact in tumor cells to promote their growth, migration and invasion. Additional experiments and analyses that supported the theoretical models for the interaction have been performed in response to the reviews. The overall findings and conceptual framework are important and the evidence is solid. A logical extrapolation of this work is to test the C1QBP mutants using functional assays to determine whether the mutations can decrease the protein stability mediated by the interaction with PA28g.

    Reviewed by eLife

    This article has 13 evaluationsAppears in 1 listLatest version Latest activity
  9. PRMT1-mediated metabolic reprogramming promotes leukemogenesis

    This article has 24 authors:
    1. Hairui Su
    2. Yong Sun
    3. Han Guo
    4. Chiao-Wang Sun
    5. Qiuying Chen
    6. Szumam Liu
    7. Anlun Li
    8. Min Gao
    9. Rui Zhao
    10. Glen Raffel
    11. Jian Jin
    12. Cheng-Kui Qu
    13. Michael Yu
    14. Christopher A Klug
    15. George Y Zheng
    16. Scott Ballinger
    17. Matthew Kutny
    18. Long X Zheng
    19. Zechen Chong
    20. Chamara Senevirathne
    21. Steven Gross
    22. Yabing Chen
    23. Minkui Luo
    24. Xinyang Zhao
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This study reveals that PRMT1 overexpression drives tumorigenesis of acute megakaryocytic leukemia (AMKL) and that targeting PRMT1 is a viable approach for treating AMKL. After revision, both reviewers found that these findings are important and that the data supporting these findings are convincing. Furthermore, these findings likely have significant implications for the treatment of AMKL with PRMT1 overexpression in the future.

    Reviewed by eLife

    This article has 7 evaluationsAppears in 1 listLatest version Latest activity
  10. Reduced mitochondrial transcription sensitizes acute myeloid leukemia cells to BCL-2 inhibition

    This article has 11 authors:
    1. Laleh S Arabanian
    2. Jenni Adamsson
    3. Anke Unger
    4. Raffaella Di Lucrezia
    5. Tim Bergbrede
    6. Arghavan Ashouri
    7. Erik Larsson
    8. Peter Nussbaumer
    9. Bert M Klebl
    10. Lars Palmqvist
    11. Claes M Gustafsson
    This article has been curated by 1 group:
    • Curated by eLife

      eLife Assessment

      This solid study assesses a mitochondrial polymerase inhibitor in combination with the BCL-2 inhibitor venetoclax, with the aim to increase the elimination of acute myeloid leukemia. It provides valuable findings of combinatorial efficacy using preclinical models in vitro and in vivo, confirming the overall importance of targeting oxidative phosphorylation to overcome venetoclax resistance in acute myeloid leukemia, and could be strengthened through mechanistic studies demonstrating on target effects and pharmacodynamic efficacy in vivo. The study is of interest to hematologists because it addresses a key biomedical issue in acute myeloid leukemia (venetoclax resistance) and provides data regarding the safety and activity of a novel inhibitor of the mitochondrial polymerase in combination with venetoclax.

    Reviewed by eLife

    This article has 7 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 8 of 44 Next